Navigation Links
MimiVax presenting at Biotech Showcase; Attending JP Morgan 2017 Healthcare Conference

MimiVax to present at Biotech Showcase; attending JP Morgan 2017 Healthcare Conference

MimiVax, LLC will be presenting at the 9th Annual Biotech Showcase Conference in San Francisco, Jan 9-12, 2017. The company will provide an overview and update on its immuno-oncology programs. Company will be highlighting its lead program SurVaxM that is in ongoing Phase II clinical study in patients with newly diagnosed glioblastoma. Besides its late stage SurVaxM program, company will share for the first time its preclinical pipeline of assets. This includes monoclonal antibody (Sur-MAb) and CAR-T/Adaptive T-cell therapy program. The 9th Annual Biotech Showcase Conference presentation will be on Tuesday January 10th at 10:15AM, at the Hilton San Francisco.

MimiVax will also be in attendance for The J.P. Morgan 35th Annual Healthcare Conference, taking place between Jan. 9 – 13, 2017 at the Westin St. Francis Hotel. During the event, MimiVax executives (CSO; Michael Ciesielski, PhD and VP, BD; Anil Goyal, PhD) will be available for meetings to discuss investment and pharmaceutical partnership opportunities.

2017 Biotech Showcase Conference:
Presenting, Tuesday, Jan. 10, 2017, 10:15 AM;
Hilton San Francisco Union Square, Room 9 Ballroom Level, San Francisco, CA

JP Morgan 2017 Healthcare Conference:
Monday - Friday, Jan. 9 - 13, 2017; Westin St. Francis Hotel, San Francisco, CA

About MimiVax: MimiVax is a privately held, clinical-stage biotechnology company focused on the development and commercialization of immunotherapeutics and targeted therapies for the treatment of cancer. Our proprietary product portfolio is based on technology licensed from Roswell Park Cancer Institute that targets survivin, a cell-survival protein that is present in most cancers and rarely detectable in normal tissue. Our therapies are designed to stimulate immune responses to control tumor growth and recurrence.

About SurVaxM: SurVaxM, our lead immunotherapeutic candidate, has demonstrated safety and tolerability and strong efficacy signal in a Phase I study in patients with malignant gliomas (brain tumors). SurVaxM is an “engineered immune activating novel/neo antigen” applicable across most histologies. SurVaxM’s single long peptide (SLP) is engineered to be activating to mid-affinity T cell receptors. Mid-affinity T cell receptors have been shown to be critical for sustained T effector activation and durable T cell responses.   

SurVaxM is currently being evaluated in a Phase II clinical trial in adults with newly diagnosed glioblastoma, and a Phase I clinical trial in combination with REVLIMID® (lenalidomide) as a maintenance therapy for adults with multiple myeloma (a form of blood cancer).

Read the full story at

Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved

Related medicine news :

1. 2017 iaedp™ Symposium Continues Tradition of Presenting the Latest in Eating Disorder Treatment with Top Professionals in U.S.
2. Presenting Channeled Messages for Higher Spiritual Awareness
3. HRA - Healthcare Research & Analytics Executives Presenting at PBIRG 55th Annual General Meeting
4. Florida Hospital Clinches the Presenting Sponsor of the 2016 Tampa Bay Lightning Playoffs and Stanley Cup Finals for the Second Year in a Row
5. Christian Bogner, MD Presenting At The Holistic Cannabis Summit
6. The Oncology Institute of Hope & Innovation Partners with Wellpoint and Stanford in Presenting a Tri-Part Research Collaboration at the 2016 ASCO Quality Care Symposium
7. Clearshark Named Presenting Sponsor of 2016 Iron Girl Columbia Triathlon
8. Four-Week Countdown: 2016 iaedp™ Symposium Continues Tradition of Presenting the Latest in Eating Disorder Treatment with the Country’s Top Professionals
9. Dr. Zaidan Presenting An Educational Seminar On Endometriosis
10. Care Logistics Presenting at the Conference of Metropolitan & Regional Hospital Associations Annual Meeting
11. NATA and the PATS Join Congressman Ryan Costello in Presenting the NATA Safe Sports School Award to Spring-Ford High School
Post Your Comments:
(Date:12/6/2018)... ... December 06, 2018 , ... ... tropical disease schistosomiasis significantly faster than the drug most commonly used against the ... Democratic Republic of Congo. The study’s authors, including a professor and two research ...
(Date:12/5/2018)... ... December 05, 2018 , ... Adam ... has been reappointed to serve on Philadelphia Mayor James F. Kenney’s Commission on ... those who identify with a cognitive or physical disability. Devlin serves as the ...
(Date:12/5/2018)... ... December 05, 2018 , ... A well-known name in the world of gyms ... Wellbeats , which has delivered on-demand, virtual fitness programming to employers, gyms and ... Available now in the Apple App Store, the Wellbeats app is fitness that fits ...
(Date:12/5/2018)... ... December 05, 2018 , ... Since PermaLip™ implants are ... are invisible to the naked eye, ensuring a natural look. “I always double and ... are no signs of implant visibility,” says Dr. Jessica Kulak, double board certified facial ...
(Date:12/5/2018)... ... , ... Domenic Palmieri has been named chief operating officer ... for the executive oversight of operations for three core divisions within HM, including ... position,” Tom Doran, president, HM Insurance Group, said. “And while we had significant ...
Breaking Medicine News(10 mins):
(Date:12/6/2018)... ... , ... Last year, 172 children deaths were reported for the 2017-18 flu ... the vaccine. Vaccination is the first step in protecting against the flu for people ... illness if infected. Along with getting vaccinated, people can take active steps to limit ...
(Date:12/5/2018)... (PRWEB) , ... December 05, 2018 , ... Smile Brands ... in a row moving from the 43rd to 25th position on the list ... Awards program, now in its 11th year, relies solely on the input of employees, ...
(Date:12/5/2018)... (PRWEB) , ... December 04, 2018 , ... ... highest marks possible for patient safety and quality. Today, the prestigious Leapfrog Group, ... country and Florida Hospital Carrollwood, Florida Hospital Heartland Medical Center Sebring, Florida Hospital ...
Breaking Medicine Technology: